Drug Type nanobody-based PROTAC |
Synonyms MVHL‑Nb170 |
Action modulators |
Mechanism influenza virus nucleoprotein modulators(influenza virus nucleoprotein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Preclinical | China | 15 May 2026 |





